Cuba's neuroscience centers offer individualized programs for patients with mild cognitive impairment (MCI) and mild-to-moderate Alzheimer's disease. The approach combines neuroprotective biotechnology (NeuroEPO), intensive cognitive rehabilitation, neuropsychological therapy, pharmacological management, and caregiver education within a humanized, multidisciplinary care model — coordinated for international patients at Havana's leading neurological institutions.
Request a medical opinion
Colorado-based physician Dr. Bill Blanchet has spent years researching Cuba's biopharmaceutical industry. In this in-depth interview he explains the science behind NeuralCIM (NeuroEPO), Cuba's trial results, real patient improvements in his own clinic, and why he believes this treatment could change millions of lives. Produced by Belly of the Beast, an independent US media outlet.
Source: Belly of the Beast — independent US media. Views expressed are those of the speakers. This video is provided for informational purposes only and does not constitute medical advice.
A quick side-by-side overview of duration, core therapies, and eligibility across our treatment programs. Tap a program to focus on it, or compare them all.
All durations are on-site in Havana. Final eligibility is determined by Cuban specialists after reviewing the patient's medical records. A remote pathway is available for patients who cannot travel.
Every stage of your treatment in Cuba is coordinated for safe healing and lasting recovery — with continued telemedicine support once you return home.
Warm airport reception by our multilingual team and comfortable transfer to your accommodation or the CIREN neuroscience facility.
At CIREN, a dedicated multidisciplinary team conducts neurological examination, neuropsychological testing, neuroimaging review (MRI/PET), and laboratory screening to confirm cognitive stage and design the individualized program.
Daily multidisciplinary therapy — cognitive rehabilitation, neuropsychology, occupational and speech therapy — with NeuroEPO neuroprotective support where indicated and pharmacological management.
Final cognitive reassessment, a personalized home-continuation plan, structured caregiver education on cognitive stimulation and daily routines, and follow-up scheduling.
A comprehensive medical report and home-continuation program so families can sustain cognitive stimulation, medication, and daily-function support.
Periodic remote cognitive reassessment and telemedicine consultations with your Cuban neurology team to track progression and adjust the plan over time.
Developed by Cuba's Center of Molecular Immunology (CIM), NeuralCIM® is a low-sialic-acid erythropoietin applied in neuro-care for its neurotrophic and neuroprotective properties — supporting neuronal survival and recovery.
Product specification
Injectable solution · 0.5 mL (0.5 mg) · Hospital administration · Store 2–8 °C
Produced by the Center of Molecular Immunology in Havana.
Aimed at protecting neural tissue and supporting brain function.
Delivered under direct medical supervision throughout the program.
Coordinated with caregiver education and follow-up support.
Each program is individualized based on diagnosis, stage, and overall health — combining medical therapy with intensive rehabilitation and monitoring.
Structural neuroimaging (MRI), neuropsychological testing, and standardized cognitive scales (MMSE, MoCA, ADAS-Cog) establish diagnosis, staging, and a baseline for treatment.
Low-sialic-acid erythropoietin from Cuba's Center of Molecular Immunology (CIM), administered in-hospital for its neurotrophic and neuroprotective properties supporting neuronal survival.
Structured, repeated training targeting memory, attention, language, and executive function — designed to preserve independence in daily activities.
Symptomatic medication carefully coordinated and monitored, alongside behavioral strategies to manage mood, sleep, and agitation.
Diet, physical activity, and wellness guidance oriented toward brain health and overall well-being.
Four-week program cycles with structured discharge and coordinated remote aftercare with your US physician.
A comprehensive baseline informs the individualized plan and enables objective progress measurement.
Cuban biotech neuroprotective therapy delivered in-hospital under medical supervision.
Individualized cognitive training to reinforce memory, attention, and executive function.
Guided movement and exercise to support mobility, balance, and overall brain health.
Intervention for language and communication difficulties where indicated.
Symptomatic medication management, monitored and adjusted throughout the program.
Structured counseling and training for families supporting a loved one at home.
Timeframe: 3–7 days
Neurological exam, neuropsychological testing, neuroimaging review, and laboratory screening to confirm cognitive stage and design the individualized program.
Timeframe: 4–6 weeks
Daily multidisciplinary therapy — cognitive rehabilitation, neuropsychology, occupational and speech therapy — with NeuroEPO support where indicated and pharmacological management.
Timeframe: 3–5 days
Final cognitive reassessment, personalized home-continuation plan, caregiver training, and follow-up scheduling before return home.
What to arrange before you travel, and how to sustain progress after you return home.
Provide recent neuropsychological assessments, MRI/PET, and laboratory results so the neurology team can confirm cognitive stage and plan the program.
Share a full medication list including dosages; cholinesterase inhibitors and other drugs may be adjusted by your neurologist.
Arrange for a family member or caregiver to attend the program — caregiver training is essential for home continuation.
Note daily-living abilities, behavioral changes, and recent functional decline to help the team tailor therapy and safety planning.
Perform the prescribed cognitive exercises and stimulation activities consistently — regular practice is the strongest predictor of maintained function.
Administer all medications exactly as prescribed and report any side effects or behavioral changes to your neurologist promptly.
Use the communication, routine-structuring, and safety strategies learned in Havana to support daily functioning and reduce confusion.
Encourage gentle exercise, social engagement, and meaningful daily routines to support mood and cognition.
Schedule periodic cognitive reassessment (in person or via telemedicine) to track progression and adjust the plan.
Interactive epidemiological data on Alzheimer's and dementia prevalence, treatment rates, early diagnosis, and mortality — the neurological conditions Cuba specializes in treating.
Diagnosed Cases: 7.40M
Diagnosed Cases
7,400,000
Annual Deaths
125,800
Mortality Rate
2%
Receiving Treatment
28%
Early Diagnosis Rate
25%
Diagnosis Rate / 1,000
22
NeuroCuba's comprehensive neurological care — including NeuroEPO — improves treatment access, early diagnosis, and cognitive stabilization compared to regional averages.
Mortality Rate
Treatment Access Rate
Early Diagnosis Rate
Data derived from WHO 2025 Dementia Report, Alzheimer's Disease International, Alzheimer's Association 2026, and GBD 2021. Figures are epidemiological estimates for informational purposes and are not clinical guarantees. NeuroCuba treatment outcomes represent documented program results for international patients.
World-class Cuban institutions, pioneering biotechnology, and complete concierge care — the reasons patients from 40+ countries trust NeuroCuba with their treatment.
Native-language coordinators in Arabic, Turkish, French, German, English, and more guide you through every step of your medical journey.
Visa processing, airport reception, accommodation, interpreters, and round-the-clock coordination — every detail handled from inquiry to return home.
Access unique neuroprotective therapies developed by Cuba's leading research institutions — including NeuroEPO (Neuralcim) — available through Cuba's medical system.
Decades of medical excellence with patients treated from over 40 countries, backed by WHO-recognized research institutions and experienced specialists.
Assessment, therapy, and rehabilitation delivered in one coordinated program by a single medical team — the Cuban model that achieves strong functional outcomes.
Special-diet meals, prayer space where available, and culturally aware care that honors your faith, customs, and family throughout your stay in Cuba.
The program is indicated for patients with mild cognitive impairment or mild-to-moderate Alzheimer's disease. Suitability is determined through individual medical review of cognitive testing, neuroimaging, laboratory results, overall health, and caregiver support capacity. Each patient is assessed individually by our neurology team.
All requirements reviewed. You're ready to request a medical opinion from our neurology team.
Submit Consultation RequestRead firsthand accounts from international patients who completed their medical journeys with us.
The multidisciplinary memory care program slowed my father's cognitive decline and gave our family precious additional time together. The caregivers were extraordinary.
Sarah W.
United Kingdom
The neurological restoration program at CIREN gave me hope when doctors in three other countries said nothing more could be done. After six weeks in Havana, my mobility improved significantly.
Ahmed K.
United Arab Emirates
Direct answers to the questions international patients ask most about this treatment in Cuba.
Costs vary based on the patient's diagnosis, program duration, and level of care required. Because each program is personalized following a medical evaluation, NeuroCuba provides a detailed cost breakdown as part of the treatment proposal. Submit a consultation request to receive a personalized estimate.
International bank transfers should be in Euros, British Pounds, or Canadian Dollars. USD transfers are not accepted. The online payment gateway accepts Visa, MasterCard, Maestro, and American Express. Cash is not accepted.
The treatment proposal details all included services. Accommodation for accompanying family members can be arranged at various comfort levels. NeuroCuba's coordinators help families choose appropriate accommodation and provide transparent pricing for all additional services.
Eligibility is determined through a comprehensive medical review by Cuba's neurology team. Submit neuropsychological testing, brain MRI, blood work, and current medication list through NeuroCuba's secure portal. The team reviews the records and responds within 5–10 business days with a treatment recommendation. The review is complimentary — there is no obligation to travel.
NeuralCIM® is typically indicated for mild cognitive impairment (MCI), mild Alzheimer's, and moderate Alzheimer's disease. Patients with severe Alzheimer's (late stage) are typically not candidates, as extensive neuronal loss limits the potential benefit. The medical team determines eligibility based on the individual's cognitive stage and overall health.
HSA and FSA funds may be usable for qualified medical expenses abroad, including treatment in Cuba. However, you should consult your plan administrator to confirm eligibility. NeuroCuba provides comprehensive medical documentation and invoices that may support HSA/FSA reimbursement. Payment is via secure online gateway (U.S. credit cards accepted) or international bank transfer in EUR, GBP, or CAD.
Peer-reviewed research on NeuroEPO (NeuralCIM®) and intranasal erythropoietin in Alzheimer's disease — the scientific basis behind Cuba's neuroprotective approach.
Sosa S, Bringas G, Urrutia N, et al. (ATHENEA Investigators)·Alzheimer's Research & Therapy, 2023;15:215
A Cuban randomized clinical trial in mild-to-moderate Alzheimer's evaluating intranasal NeuroEPO (NeuralCIM®), developed by the Center of Molecular Immunology (CIM) and coordinated with CIREN.
View publicationRodríguez Y, Strehaiano M, Rodríguez T, García JC, Maurice T·Journal of Alzheimer's Disease, 2017;55(1):231–248
Preclinical study showing intranasal NeuroEPO prevented memory deficits and amyloid toxicity in an Alzheimer's transgenic mouse model.
View publicationMaurice T, Mustafa MH, Desrumaux C, Keller E, Naert G, et al.·Journal of Psychopharmacology, 2013;27(11):1044–1057
Preclinical evidence that intranasal erythropoietin protected against amyloid-induced toxicity in an Alzheimer's mouse model.
View publicationThese peer-reviewed studies are included for informational purposes. Treatment eligibility and decisions are determined by the medical team following an individualized patient evaluation; research findings do not guarantee an individual outcome.
Bilingual (Spanish/English) printable brochures summarizing this program. Download to review offline, share with family, or discuss with your physician.
8 pages
A comprehensive guide to NeuroCuba's Alzheimer's restoration program — covering NeuralCIM® therapy, the 4-week structure, continuity of care, and caregiver support.
7 pages
A side-by-side summary of the Alzheimer's, Parkinson's, and NeuroRestoration programs — comparing focus, duration, core therapies, eligibility, and follow-up so families can choose the right starting point. Print-ready for offline review.
On-site neuroimaging, neuropsychological testing, laboratory work, and multidisciplinary assessment to finalize the individualized treatment plan.
Three weeks of daily NeuralCIM® neuroprotective therapy, cognitive rehabilitation, and physical activation per the medical team's plan.
Delivered by a coordinated team of specialists across multiple disciplines, supporting the patient and family throughout the journey.
Caring for a loved one with Alzheimer's or Parkinson's is a journey the whole family shares. These practical tips, guides, and resources help you manage daily needs with confidence and compassion — at home and across borders.
Remove tripping hazards, install grab bars in bathrooms, secure loose rugs, and improve lighting in hallways and stairways to reduce fall risk and wandering incidents.
Offer nutrient-dense, easy-to-eat meals. Use adaptive utensils, serve smaller portions, and maintain a consistent meal schedule to support appetite and medication timing.
Establish a calm evening routine, limit daytime naps, reduce stimulation before bed, and keep the bedroom dark and cool to ease restlessness and nighttime confusion.
Predictable schedules for waking, meals, activities, and medication reduce anxiety and help preserve a sense of control for both patient and caregiver.
Encourage regular, meaningful interaction with family and friends. Social engagement supports mood and cognition and slows the sense of isolation.
Labels, clocks, calendars, photo albums, and simple written reminders help reinforce orientation and support independence in daily tasks.
A step-by-step introduction for families newly navigating an Alzheimer's or Parkinson's diagnosis — what to expect, what to plan, and where to begin.
Practical tips for tracking prescriptions, recognizing side effects, coordinating with your US physician, and timing doses around the Cuban treatment program.
Techniques for responding to confusion, agitation, and repetitive questions with patience — and strategies for clear, reassuring communication.
When to call your physician, how to prepare for a remote consultation with Havana specialists, and how to coordinate care across borders.
Our patient coordination team connects families with structured support before, during, and after the Cuban treatment program.
After your four-week program in Havana, you return home with a structured care plan. Your Cuban medical team continues follow-up through weekly or monthly telemedicine consultations to observe status changes, monitor movement and cognition, and keep your recovery on track.
Leave Havana with a structured discharge plan, full clinical reports for your US physician, and a clear home-continuation guide.
Scheduled remote check-ins with your Cuban medical team to review progress and adjust guidance over time.
Ongoing observation of cognitive and motor status, tracking changes in movement, function, and quality of life.
Clinical reports and follow-up notes shared with your doctor at home for seamless continuity of care.
You access our services through the Coordination and Processing Center, where a specialist immediately responds to your request and assesses whether you require the service — and you can also access an online consultation prior to your trip.
Head of the Coordination and Processing Center
Doctor in Medicine, First Degree Specialist in Comprehensive General Medicine. Master in Primary Health Care. Certified in Foreign Trade.
Commercial Specialist, International Medical Services
Doctor in Medicine. First Degree Specialist in Comprehensive General Medicine. Master in Marketing and Social Communication. Certified in Foreign Trade.
Commercial Specialist, International Medical Services
Doctor in Medicine. First Degree Specialist in Comprehensive General Medicine. Certified in Nutrition and Foreign Trade.
Commercial Specialist, International Medical Services
Doctor in Medicine, First Degree Specialist in Comprehensive General Medicine. Master in Medical Emergencies.
Commercial Specialist, International Medical Services
Doctor of Medicine. First-Degree Specialist in Psychiatry. Certified in Medical Emergencies and Urgent Care. Bachelor of Science in Nursing.
Commercial Specialist, International Medical Services
Bachelor's Degree in German Language and Scientific-Technical Information. Certified in Technical Information Processes, Foreign Trade, Foreign Investment, and International Cooperation.
We are here to help you with personalized, safe and high-quality medical solutions. Submit a consultation request and our medical team will review your case within 24–48 hours.
We've set the website to English based on your location. You can change this anytime.
United States→English
